NCT01380743View on ClinicalTrials.gov

Drug-drug Interaction Study

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 4, 2013

Study Completion Date

January 4, 2013

Conditions
Pompe Disease
Interventions
DRUG

duvoglustat

Single oral dose

DRUG

rhGAA

Single intravenous infusion

Trial Locations (15)

22152

Springfield

27710

Durham

30033

Decatur

32610

Gainesville

45299

Cincinnati

59405

Great Falls

66160

Kansas City

75013

Paris

85018

Phoenix

85258

Scottsdale

92868

Orange

97239

Portland

L8N 3Z5

Hamilton

WC1N 3BG

London

M68 HD

Salford

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY

NCT01380743 - Drug-drug Interaction Study | Biotech Hunter | Biotech Hunter